Download FREE Sample
Table of Contents
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Market Forecasting
- Executive Summary
- Market Overview
-
- Market Dynamics
- Drivers
- Restraints
- Key Market Trends
- Industry Speaks
- Market Dynamics
- Key Revenue Pockets
- Global Pharma CCO Market - Size & Forecast (2021-2028), By Services
- Strategic Consulting
- Market Access (Including RWE and HEOR)
- Pricing & Reimbursement
- Medical Affairs
- Regulatory & Compliance
- Other Services (Data & Analytics and Marketing Services - HCP Engagement, Patient Engagement, Promotional Strategies)
- Global Pharma CCO Market - Size & Forecast (2021-2028), By Business Model
- Tech/Data Enabled and/or Subscription Model
- Consulting Model
- Global Pharma CCO Market - Size & Forecast (2021-2028), By End User Type
- Pharma
- MedTech
- Healthcare Providers
- Payors
- Other End Users
- Global Pharma CCO Market - Size & Forecast (2021-2028), By Region
- North America (U.S. & Canada)
- Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
- Asia Pacific (China, India, Japan, Rest of Asia Pacific)
- Rest of the World (Latin America, Middle East & Africa)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Competitive Positioning of Key Players (2022)
- Offerings Assessment, By Player
- Key Strategies Assessment, By Player (2021-2023)
- New Product & Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Key Companies Scanned (Indicative List)
- EVERSANA
- IQVIA
- Certara
- Indegene
- Real Chemistry
- Lucid Group
- Syneos Health
- Genesis Research
- Avalere Health
- Cheors
- Avid Bioservices
- Other Prominent Players
